About
Acceptance rate:
31%
Time to first decision:
7 days
Time to first decision with review:
52 days*
Acceptance to publication:
26 days*
Impact factor:
3.6
Citescore:
5.7
Aims and scope
Sexually Transmitted Infections (STI) keeps clinicians and researchers up to date on the transmission, prevention, diagnosis, natural history and treatment of STIs and HIV. This includes existing and emerging infections where sexual transmission plays a role, as well as related aspects of sexual health.
The journal publishes original research, reviews, editorials and correspondence on the clinical, translational, laboratory, public health and sociological aspects of infections from around the world. STI also publishes a blog and podcasts to promote wider communication and dissemination of new developments in the field.
STI is an official journal of the British Association of Sexual Health and HIV (BASHH).
For information about the Editor-in-Chief Anna Maria Geretti and her editorial team, please refer to the Editorial Board page.
Plan S compliance
Sexually Transmitted Infections is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.
Journal information
Ownership
Sexually Transmitted Infections is owned by BMJ
Publication model
Subscription; with hybrid open access option
Frequency
8 issues per year
Launch date
1925
Indexed by
Web of Science Core Collection: Science Citation Index, Science Citation Index Extended; BIOSIS Reviews, Current Contents: Clinical Medicine, Life Sciences, MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Exerpta Medica), CINAHL, Google Scholar
Peer Review Model
Peer review model: Single anonymised; the names of reviewers are hidden from the author
Print ISSN
1368-4973
Online ISSN
1472-3263
Journal Statistics 2023
Acceptance rate: 31%
Speed
Time to first decision without review (median): 7 days
Time to first decision with review (median): 52 days
Time from acceptance to publication (median): 26 days
Impact
Impact Factor category: Infectious Diseases
Impact factor (JCR): 3.6
Impact Factor rank: 42/132
5 Year Impact Factor: 3
Journal Citation Indicator: 0.61
Eigenfactor Score: 0.00484
Citescore: 5.7
Citescore rank: 123/344
SciMago Journal Rank: 1.04
Reach
Total content views: 562,947
Total Altmetric mentions: 846
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
How we get these metrics
Contact information
For all contact information please refer to the contact us page.
For authors
Please refer to the Instructions for authors
Subscriptions
To advertise
Rights and permissions
Affiliations
The British Association for Sexual Health and HIV - BASHH - was formed through the merger, in 2003, of the Medical Society for the Study of Venereal Diseases (MSSVD, established 1922) and the Association for Genitourinary Medicine (AGUM, established 1992).
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.